Le Lézard
Classified in: Health, Science and technology
Subject: CCA

Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2023 Financial Results


WARSAW, Ind., Jan. 16, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter earnings conference call will be webcast on Thursday, February 8, 2024 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET.

The live audio webcast can be accessed via Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com. It will be available for replay following the conference call.

Individuals in the U.S. and Canada who wish to dial into the conference call may do so by dialing (888) 204-4368 and using conference ID 5103691. International callers should dial +1 (323) 994-2093 and use conference ID 5103691.

Additionally, Zimmer Biomet will host an in-person product showcase event for investors and analysts at the American Academy of Orthopaedic Surgeons Conference in San Francisco. The event will take place on Tuesday, February 13, 2024 at 5:30 p.m. PT. Please register prior to attending the event via Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com/news-and-events/events-and-presentations.

About Zimmer Biomet

Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.

With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation. 

For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.

Media
Heather Zoumas-Lubeski
(445) 248-0577
[email protected]

Investors
Zach Weiner
(908) 591-6955
[email protected]

SOURCE Zimmer Biomet Holdings, Inc.


These press releases may also interest you

at 02:43
Reverse Logistics Market to Reach $947.7 billion, Globally, by 2032 at 4.3% CAGR: Allied Market Research
Allied Market Research published a report, titled, "Reverse Logistics Market by Return Type (Recalls, Commercial Returns & B2B Returns, Repairable...

at 02:31
Munters announces increased net sales growth target, new strategic sustainability targets and commitment to the Science Based Targets initiative
Munters has increased its financial mid-term target for net sales growth and updated its strategic sustainability targets, including a commitment to the Science Based Targets initiative (SBTi). The net sales growth target and the strategic...

at 02:21
Elbit Systems Awarded a Group of Contracts in an Aggregate Amount of Approximately $760 Million for the Supply of Ammunitions to the Israeli Ministry of Defense
Elbit Systems Ltd.  ("Elbit Systems" or the "Company") announced today, further to the report in its Annual Report on Form 20-F for the year ended December 31, 2023, filed on March 28, 2024, that it was awarded a group of contracts in an aggregate...

at 02:05
OneStock Announces $72 Million Investment to Help Brands Unlock Their Full Omnichannel Potential
OneStock SAS, a leading provider of Order Management Systems (OMS), today announced a $72 million investment from global growth equity investor Summit Partners. OneStock was founded in 2015 by CEO, Romulus Grigoras, and CTO, Benoit Baccot, to help...

at 02:05
AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030
Today AstraZeneca revealed its bold ambition to deliver $80 billion in Total Revenue by 2030, up from $45.8 billion in 2023. This will be achieved through significant growth in its existing oncology, biopharmaceuticals and rare disease portfolio, and...

at 02:00
ASOTO and CATALSYS Form Strategic Joint Venture to Provide Revolutionary Green Energy Solutions for AI Data Centers
ASOTO OÜ and CATALSYS Limited are thrilled to announce a strategic joint venture aimed at transforming the European data-center industry through innovative green-energy solutions. This partnership combines ASOTO's expertise in off-grid power...

More news about Science and technology...


News published on and distributed by: